Cytomegalovirus infection after liver transplantation: Current concepts and challenges

Figure 1 Time to the onset of CMV disease in solid organ transplant recipients who received 3 mo of oral ganciclovir or valganciclovir prophylaxis. Data obtained from the study by Paya et al[5].

Figure 2 The proportion of solid organ transplant patients with resolution of clinical symptoms (A) and viremia eradication (B) at day 21 and 49 following the start of valganciclovir or IV ganciclovir treatment of CMV disease. Data obtained from the study by Asberg et al[81].